Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06617039

The Impact of Low-Dose Esketamine Combined With Ciprofol on the Quality of Early Postoperative Recovery Among Elderly Patients Undergoing Painless Gastroscopy

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
376 (estimated)
Sponsor
Northern Jiangsu People's Hospital · Academic / Other
Sex
All
Age
60 Years – 75 Years
Healthy volunteers
Accepted

Summary

To explore the impact of esketamine combined with ciprofol on the quality of early postoperative recovery in elderly patients undergoing painless gastroscopy, as well as the effectiveness and safety of this regimen.

Conditions

Interventions

TypeNameDescription
DRUGRemifentanil and ciprofolR group will be started with remifentanil 0.5ug/kg and ciprofol 0.4 mg/kg.
DRUGesketamine 0.3mg/kg and ciprofolAnesthesia induction was initiated by esketamine 0.3mg/kg, followed by ciprofol 0.2-0.4mg/kg.
DRUGesketamine 0.5mg/kg and ciprofolAnesthesia induction was initiated by esketamine 0.5mg/kg, followed by ciprofol 0.2-0.4mg/kg.
DRUGCiprofolCiprofol group will be started with ciprofol 0.2-0.4 mg/kg.

Timeline

Start date
2024-10-10
Primary completion
2025-07-15
Completion
2025-07-15
First posted
2024-09-27
Last updated
2025-05-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06617039. Inclusion in this directory is not an endorsement.